ArticlePDF Available

Validation of the Broca index as the most practical method to calculate the ideal body weight

Authors:
Research Article
Journal of Clinical Investigation and Studies
J Clin Invest Stud, 2018 doi: 10.15761/JCIS.1000105 Volume 1(1): 1-4
ISSN: 2631-4002
Validation of the Broca index as the most practical method
to calculate the ideal body weight
Weber-Sanchez Alejandro1*, Velázquez Ortega Sofía2 and Weber-Álvarez Pablo3
1General Surgery Department, Hospital Ángeles Lomas, México
2Nutriologist, Hospital Angeles Lomas, México
3General Physician, Hospital Angeles Lomas, México
Abstract
Ideal body weight (IBW) calculation is useful in clinical practice, but most of the formulas to calculate it are complicated. Broca index (BI) is still a simple and
eective method to determine IBW although seems to be abandoned. Our objective is to verify validity of BI compared with Hammond and Robinson formulas,
and with IBW calculated from ideal body mass index (BMI) (22.5kg/m2) in a population. We made a correlational study from 400 patients of nutrition and surgery
consult, from 2010 to 2015. Patients were classied according to their BMI in group A <30kg/m2 and B ≥30kg/m2. Age, sex, height and weight, were recorded to
calculate IBW with Hammond, Robinson and BI formulas and the IBW calculated from ideal BMI. we analyzed, statistical signicance with student’s t test, Pearson
coecient and linear regression. Of the 400 patients, 221 were group A, 49.7% men, and 50.3% women. Average age, height, actual weight and actual BMI were
38.9years-old, 167cm, 67.6kg, and 24.1kg/m2 respectively; and group B, 179 patients; 44.6% men, 55.4% women. Average age, height and actual weight, and actual
BMI were 38.4years-old, 168cm, 112.3kg and 39.7kg/m2 respectively.
Both groups showed normal distribution. When comparing IBW using BI, with the other formulas analysed with t-test, result was signicant in all (p 0.000).
Utilizing Pearson coecient also all showed signicance (p 0.000) for both groups. Linear regression with Hammond, Robinson formulas and weight calculated from
ideal BMI showed relationship of 95.7%, 96.5% and 99.8% respectively and between the 4 IBW formulas together, 100% relationship for both groups.
BI seems to oer the same accuracy as other more complex formulas for the calculation of the IBW. BI continues to have validity and utility in clinical practice, so we
promote it as a useful clinical tool because of its simplicity.
*Correspondence to: Alejandro Weber Sánchez, MD, Vialidad de la Barranca
s/n C410, Valle de las Palmas, Huixquilucan, 52763, Estado de México, México,
Tel: 52469527; E-mail: awebersanchez@gmail.com
Key words: body mass index, weight calculation, weight equations, weight
formulas
Received: June 07, 2018; Accepted: June 14, 2018; Published: June 19, 2018
Introduction
Weight and height are the simplest, practical and most common
anthropometric measures to initially assess the general nutritional
status and ideal body weight (IBW) patients should have, and are
useful in clinical practice, particularly for the general physician.
ere are many formulas to calculate the IBW, most of them are
complicated and require charts or calculators. e Broca index (BI)
(height in centimeters-100=IBW) despite having more than 100 years
of formulated, is still a valid and eective method to determine IBW
with the benet of its simplicity although nowadays seems to be
abandoned.
e body mass index (BMI) has been used since the seventies as the
main criteria to dene the desirable range of weight according to the
constitution of the patient, and it is used as an indicator of the severity
of obesity with implications in morbidity and mortality. e IBW
calculated with BI correlates with the weight calculated from ideal BMI
of 22.5 kg/m2 associated with the lowest mortality rate, which makes it
a useful tool, easy to obtain in clinical practice [1].
Objective
Verify the validity and utility of the BI to determine IBW compared
with Hammond and Robinson formulas, and with the weight calculated
from ideal BMI (22.5kg/m2) [2], both in non- obese patients (BMI < 30
kg / m2) and obese patients (≥ 30 kg/m2).
Hypothesis
e IBW calculated with BI, adequately correlates with Hammond
and Robinson formulas, and with the weight calculated from ideal BMI
(22.5kg / m2).
Material and methods
is is a retrospective, observational, correlational and descriptive
study obtained from the clinical records of 400 patients of a nutrition
and bariatric surgery consult of our medical group, collected from
January 01, 2010 to December 31, 2015. e patients were classied in
two groups according to the BMI, patients with BMI < 30 kg/m2 (group
A) and patients with BMI ≥ 30 kg/m2 (group B). Microso® Excel v.
15.23 was used to register the following variables: age, sex, height (cm),
weight (kg), and to perform calculations of the Hammond, Robinson,
BI and weight calculated from ideal BMI (22.5kg / m2). Statistical
package for Social Sciences SPSS v. 21 was used to analyze data from
both groups separately and verify their normal distribution according
Weber-Sánchez A (2018) Validation of the Broca index as the most practical method to calculate the ideal body weight
Volume 1(1): 2-4
J Clin Invest Stud, 2018 doi: 10.15761/JCIS.1000105
to the Kolmogorov-Smirno test. Independent samples t test was used
to compare the BI (height cm - 100) with Hammond’s equation IBW=
(48kg for 150cm) + 1.1 kg/cm for men and (45kg for 150cm) + 0.9kg/
cm for women; Robinson’s equation IBW= (50kg + 0.75) X height cm
-152.4 for men and (45.5Kg + 0.67) X height cm -152.4 for women; and
with the IBW calculated from ideal BMI (22.5kg/m2) for both group A
and B, considering p<0.05 signicant. Pearson correlation coecient
and linear regression analysis were also utilized to investigate BI relation
with the other three formulas. We also analyzed Pearson correlation for
both groups separated by sex and height.
Results
Of the total population of 400 patients, 221 were assigned to group
A, of which 110 where men (49.7%) and 111 women (50.3%) with an
average age of 38.9 years old (range 19 to 66), average height of 167cm
(range 133 to 190) DS 0.09. In group B, there were 179 patients; 80 men
(44.6%) and 99 women (55.4%) with an average age of 38.4 (range of
15 to 70), average height of 168cm (range 152 to 194cm) DS 0.08. e
average of the patient´s actual weight in group A was 67.6kg DS 11.3,
and an average of actual BMI of 24.1kg/m2 DS 2.8. Group B had an
average of 112.3kg of actual weight SD 21.9, and average of actual BMI
of 39.7kg/m2 SD 5.8.
Both groups showed a normal distribution according to the
Kolmogorov-Smirno test for both weight and height. When
comparing the calculated IBW obtained using BI, with the IBW
obtained from the Hammond and Robinson’s equations, as well as with
the weight calculated from ideal BMI (22.5kg / m2) analysed with the
student's t-test for related samples, the result was signicant in all (p
0.000). Utilizing Pearson correlation coecient to contrast the BI with
the other formulas, also all showed statistical signicance (p 0.000) for
both groups, when analysed by sex and height in both groups separately
the signicance was also p 0.000.
With linear regression analysis, the BI compared with Hammond’s
equation showed a relationship of 95.7%, with Robinson’s 96.5% and
with the weight calculated from ideal BMI (22.5kg/m2) 99.8%. (Figures
1-3). e linear regression analysis between the 4 IBW formulas,
showed 100% relationship for both groups.
When compared considering dierent height ranges, <140cm, 141-
150, 151-160, 161-170, 171-180, >1.81 we found no dierences between
both groups, but minor ranges of height tend to have less correlation
with BI, and the ranges >160cm has a correlation higher than 50%.
Discussion
e most commonly used anthropometric measures used in
clinical practice to initially assess the nutritional status of an individual,
are weight and height. ey are simple, practical and easily obtained.
e calculation of the IBW of a patient has been searched for a long
time. In the middle of the 19th century, Quetelet, a Belgium astronomist,
developed an index showing that the body weight in adults was related
to the quadrate height in a constant relationship. A few years later in
1871 a French surgeon, Pier Broca, pioneer in physical anthropology
and known by his multiple works on the brain and cranial
Figure 1. Linear regression Boca’s Index and Hammond’s formula
Figure 2. Linear regression Boca’s Index and Robinson’s formula
Figure 3. Linear regression Boca’s Index and weight calculated with ideal BMI.
Weber-Sánchez A (2018) Validation of the Broca index as the most practical method to calculate the ideal body weight
Volume 1(1): 3-4
J Clin Invest Stud, 2018 doi: 10.15761/JCIS.1000105
anthropometry, introduced in clinical practice the index that bears his
name for the determination of this important parameter obtained in
adults empirically by subtracting 100cm from the patient's height [3-5].
Historically, the IBW was dened as the one associated with the
lowest mortality, which is why it has great importance. According to
the actuarial data of insurers obtained from the evaluation of weight
and height from a large healthy population, charts to obtain the IBW
were created. e rst documented table was published in 1913 by
Medico-Actuarial Mortality Investigation and subsequently in 1942 the
Metropolitan Life Insurance Company, released its own charts based
on longevity [6,7]. Because of their lack of practicality, these tables were
replaced by equations to estimate the ideal weight.
In 1963 and 1964, Hamwi [8] and Devine [9] developed and
published formulas to calculate IBW to obtain the adequate doses of
certain drugs according to it. Since then, several similar formulas and
equations have been created for the same purpose through regression
analysis of weight and height data like Robinson's [10] equation in 1983
developed with the same intention. In the same year, Miller et al. [11]
also formulated other equations based on Metropolitan Life Insurance
Company’s tables. More recently in 2000, Hammond [12] created a
metric system version from the Hamwi equation.
It was not until the end of the 1970s, when it was suggested that BMI
was preferable to other weight indexes to estimate the IBW [13]. Because
adult weight increases proportionally to the square of height, BMI has
a good correlation with fat mass with values of r 0.7 in population
studies. Gray’s paramount study in 1989 showed that in a population
of 750000 people, the BMI range between 20 to 25kg/m2 was the one
that correlated better with the lower mortality rate, and that it increased
exponentially as it increased, becoming more of 200% in patients with
BMI >40 kg/m2 [13-16]. erefore, BMI has also been used as criteria
to determine a desirable weight range and is internationally accepted
by both the World Health Organization (WHO) and the National
Institutes of Health (NIH), dening the dierent intervals to classify
patients as overweight, obesity I, II, morbid obesity or higher [16,17].
Any of the above-mentioned equations so far, as well as the ideal
BMI can be used to calculate the IBW, however, they are not easy to use
in daily clinical practice without a calculator and consumes time.
Some authors emphasize that a deeper analysis in this regard should
be done, and that we should forget both the IBW and the BMI because
of the disadvantage that they do not distinguish fat mass from fat-free
mass [12], however, studies that analyze body composition and give us
this data, are more expensive and are not available in everyday clinical
practice.
Shan et al. [1], compiled a list of IBW formulas used to evaluate
the relationship between height-weight tables and IBW equations, and
to determine which formula or table t best within the BMI of 22 kg/
m2 using linear regression and correlations, nding that most of the
slopes of the formulas fall between BMI range of 20 to 25 kg/m2, with
dierences between men and women, therefore, they proposed that
formulas could be used as a guide to asses body weight rather than
assessing weight from various height-weight tables.
Our study was aimed to assess the validity of the BI. We wanted
to know if there were dierences between Hammond and Robinson
equations and the weight calculated from ideal BMI of 22.5 kg/m2, and to
asses if there were dierences between obese and non-obese population,
as well as between men and women and dierent ranks of height, so we
divided the patients into two groups accordingly to their BMI greater
or less than 30kg/m2 and analyzed the data separately between men
and women and dierent ranges of height and to verify if there was
dierence between these groups in healthy adults. We did not include
children since the utility of this index is limited to the adult population.
Comparing the BI with the other three formulas used in this study,
the comparative analysis using the t-student statistic and Pearson's
correlation had statistical signicance in both groups (p 0.000). When
using linear regression, comparing all the mentioned formulas, a value
of 100% (R2 1,000) was obtained, which seems to corroborate that the
BI has the same accuracy as the other three equations and can be used
for this propose with condence independently of weight, BMI and
height in adults. When we compared dierent height ranges we found
that BI higher ranges have more correlation than lower ones.
Conclusion
It seems that BI oers the same accuracy as other more complex
formulas such as Hammond and Robinson’s for the calculation of the
IBW, and also correlates well with the weight calculated from ideal BMI,
and that it continues to have validity and utility in clinical practice,
so we promote its use in clinical practice in view of its simplicity and
practicality.
Conict of interest
e authors involved in this investigation declare that they don’t
have conict of interest.
Author’s contributions
Dr. Alejandro Weber: Conception and design of the investigation.
Main author, principal reviewer and investigator. General supervisor.
Lic. Sofía Ortega: Investigator and reviewer, Acquisition of data
and analysis.
Dr. Pablo Weber Alvarez: Investigator and reviewer, Statistical
analysis and interpretation of data.
References
1. Shah B, Sucher K, Hollenbeck CB (2006) Comparison of ideal body weight equations
and published height-weight tables with body mass index tables for healthy adults in
the United States. Nut Clin Pract 21:312-319.
2. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, et al. (2010)
Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363:
2211-2219. [Crossref]
3. Peterson CM, Thomas DM, Blackburn GL, Heymseld SB (2016) Universal equation
for estimating ideal body weight and body weight at any BMI. Am J Clin Nutr 103:
1197-1203. [Crossref]
4. Pai MP, Paloucek FP (2000) The origin of the "ideal" body weight equations. Ann
Pharmacother 34: 1066-1069. [Crossref]
5. Rössner S (2007) Paul Pierre Broca (1824-1880). Obes Rev 8: 277. [Crossref]
6. Metropolitan Life Insurance Company (1942) Ideal weights for men. Stat Bull Metrop
Life Insur Co 23:6–8.
7. Metropolitan Life Insurance Company (1943) Ideal weight for women. Stat Bull
Metrop Life Insur Co 24:6–8.
8. Hamwi GL. (2033) Changing dietary conceptsin therapy. In: Danowski TS, editor.
Diabetes mellitus: diagnosis and treat-ment, New York: American Diabetes Association,
p. 73-8.
9. Devine BJ (1974) Gentamicin therapy. Drug Intell Clin Pharm 8:650–655.
Weber-Sánchez A (2018) Validation of the Broca index as the most practical method to calculate the ideal body weight
Volume 1(1): 4-4
J Clin Invest Stud, 2018 doi: 10.15761/JCIS.1000105
Copyright: ©2018 Weber-Sánchez A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
10. Robinson JD, Lupkiewicz SM, Palenik L, Lopez LM, Ariet M (1983) Determination
of ideal body weight for drug dosage calculations. Am J Hosp Pharm 40: 1016-1019.
[Crossref]
11. Miller DR, Carlson JD, Lloyd BJ, Day BJ (1983) Determining ideal body ? weight (and
mass). Am J Hosp Pharm 40:1622–1625.
12. Hammond KA. (2000) Dietary and clinical assessment. In: Mahan LK, Stump SE,
editors. Krause’s food, nutrition, & diet therapy. (11th Edition), Saunders, Philadelphia,
p. 353–79.
13. Müller MJ1 (2016) Ideal body weight or BMI: so, what's it to be? Am J Clin Nutr 103:
1193-1194. [Crossref]
14. Flegal KM, Kit BK, Orpana H, Graubard BI (2013) Association of all-cause mortality
with overweight and obesity using standard body mass index categories: a systematic
review and meta-analysis. JAMA 309: 71-82. [Crossref]
15. Wang ZJ, Zhou YJ, Galper BZ, et al. (2015) Association of body mass index with
mortality and cardiovascular events for patients with coronary artery disease: a
systematic review and meta-analysis. Heart 101:1631-1638.
16. Gray DS (1989) Diagnosis and prevalence of obesity. Med Clin North Am 73:1-13.
17. Hruby A, Hu FB (2015) The Epidemiology of Obesity: A Big Picture.
Pharmacoeconomics 33: 673-689. [Crossref]
... The 1-year postoperative %EWL was calculated in accordance with other authors: (weight at baseline − weight at 12 months follow-up) / (weight at baseline − ideal body weight) × 100. Ideal body weight (IBW) was calculated from Broca's formula (height − 100) depending on the participant's gender (female: subtract 10% of the calculated value, male: subtract 5%) [27]. ...
Article
Full-text available
Background Bariatric surgeries, such as laparoscopic sleeve gastrectomy (LSG), not only result in significant weight loss but also improve the inflammatory state in obese patients. This study aimed to investigate the effects of LSG on weight loss and inflammation status in bariatric patients 1-year post-procedure. Methods This prospective cohort study was conducted from September 2022 to May 2024. Fifty obese adults were enrolled for LSG. All patients underwent assessments of body measurements, as well as levels of interleukin-6 (IL-6) and interleukin-10 (IL-10) at baseline, and then at 3 and 12 months post-surgery. Results Twelve months post-surgery, body measurements showed a significant reduction, with a median excess weight loss (%EWL) of 56.8%, indicating the clinical success of the bariatric procedure. %EWL showed a strong correlation with waist circumference (R = − 0.738, p < 0.00001). A logistic regression model indicated that a reduction of just 1 cm in initial waist circumference increases the likelihood of a positive outcome in laparoscopic sleeve gastrectomy by 12%. Moreover, a significant increase was observed for IL-10 (p < 0.0001), simultaneously with a significant decrease in IL-6 (p < 0.0001). Conclusions This study provides valuable evidence supporting the benefits of laparoscopic sleeve gastrectomy for both weight loss and reducing inflammation. Waist circumference emerged as a strong predictor of metabolic success 1-year post-surgery, while increased IL-10 levels signaled positive immunological changes.
... The one year postoperative %EWL was calculated in accordance with other authors: (weight at baseline -weight at 12 months follow-up) / (weight at baseline -ideal body weight) * 100. Ideal body weight (IBW) was calculated from Broca's formula (height -100) depending on the participants gender (female: subtract 10% of the calculated value, male: subtract 5%) [27]. ...
Preprint
Full-text available
Purpose Bariatric surgeries, such as laparoscopic sleeve gastrectomy (LSG), not only result in significant weight loss but also improve the inflammatory state in obese patients. This study aimed to investigate the effects of LSG on weight loss and inflammation status in bariatric patients one year post-procedure. Materials and Methods This prospective cohort study was conducted from September 2022 till May 2024. Fifty obese adults were enrolled for LSG. All patients underwent assessments of body measurements, as well as levels of interleukin-6 (IL-6), interleukin-10 (IL-10) at baseline, and then at 3 and 12 months post-surgery. Results Twelve months post-surgery, body measurements showed a significant reduction, with a median excess weight loss (%EWL) of 56.8%, indicating clinical success of the bariatric procedure. %EWL showed a strong correlation with waist circumference (R= -0.738, p < 0.00001). A logistic regression model indicated that a reduction of just one centimeter in initial waist circumference increases the likelihood of a positive outcome in laparoscopic sleeve gastrectomy by 12%. Moreover, a significant increase was observed for IL-10 (p < 0.0001), simultaneously with a significant decrease in IL-6 (p < 0.0001). Conclusions This study provides valuable evidence supporting the benefits of laparoscopic sleeve gastrectomy for both weight loss and reducing inflammation. Waist circumference emerged as a strong predictor of metabolic success one year post-surgery, while increased IL-10 levels signaled positive immunological changes.
... Ideal body weight (IBW) was calculated using Broca's index. [11] Height was estimated using arm span. [12] Ideal body weight was utilized to calculate the ventilator tidal volume. ...
Article
Full-text available
Background: There is scant literature comparing high tidal volume ventilation (HTV) over low tidal volume (LTV) ventilation in acute traumatic cervical spinal cord injury (CSCI). Objective: The aim of this prospective randomized controlled parallel-group, single-blinded study was to compare the effect of two different tidal volumes (12-15 mL/kg and 6-8 mL/kg) in CSCI on days to achieve ventilator-free breathing (VFB), PaO2/FIO2 ratio, the incidence of complications, requirement of vasopressor drugs, total duration of hospital stay, and mortality. Materials and methods: We enrolled patients with acute high traumatic CSCI admitted to the neurotrauma intensive care unit within 24 h of injury, requiring mechanical ventilation. Participants were randomized to receive either HTV, 12-15 mL/kg (group H) or LTV, 6-8 mL/kg (group L) tidal volume ventilation. Results and conclusions: A total of 56 patients, 28 in each group were analyzed. Patient demographics and injury severity were comparable between the groups. VFB was achieved in 23 and 19 patients in groups H and L, respectively. The median number of days required to achieve VFB was 3 (2, 56) and 8 (2, 50) days, P = 0.33; PaO2: FIO2 ratio was 364.0 ± 64 and 321.0 ± 67.0, P = 0.01; the incidence of atelectasis was 25% and 46%, P = 0.16, respectively, in group H and group L. The hemodynamic parameters and the vasopressor requirement were comparable in both groups. There was no barotrauma. The duration of hospital stay (P = 0.2) and mortality (P = 0.2) was comparable in both groups. There was no significant difference in days to achieve ventilator-free breathing with HTV (12-15 mL/kg) ventilation compared to LTV (6-8 mL/kg) ventilation in acute CSCI. The PaO2:FiO2 ratio was higher with the use of 12-15 mL/kg. No difference in mortality and duration of hospital stay was seen in either group.
Article
Full-text available
Background: Magnesium sulfate reduces opioid use and its associated side effects. However, no consensus exists on whether the optimal dosing should be based on actual body weight or adjusted ideal body weight. The primary objective of this study was to compare postoperative analgesia after magnesium sulfate infusion, using doses calculated based on actual body weight versus adjusted ideal body weight. Methods: This prospective, randomized, double-blind, controlled clinical trial included 75 participants who underwent target-controlled intravenous general anesthesia. The participants were divided into three groups: a control group (CG), a group receiving magnesium sulfate calculated by actual body weight (AWG), and a group receiving magnesium sulfate calculated based on the adjusted ideal body weight (IWG). Results: The AWG had significantly lower pain scores than the CG (p<0.001) and IWG (p=0.017). Opioid use was similar between the AWG and IWG, but significantly higher in the CG (AWG = IWG, p=0.08; CG > AWG, p<0.001; CG = IWG, p 0.03). The increase in magnesium concentration did not reach clinically relevant levels. Neuromuscular blockade latency decreased in the groups receiving magnesium sulfate (p<0.001 in both comparisons) compared to the CG. Conclusion: Calculating the dose of magnesium sulfate based on actual body weight enhances postoperative analgesia. The increase in magnesium concentration was not clinically significant and did not interfere with the action of cisatracurium in the groups receiving magnesium sulfate. Trial Registration: ClinicalTrials.gov identifier: NCT04645719
Article
Full-text available
Objective: This study was conducted to assess the nutritional status of adolescent girls using anthropometric indices. Methods: Descriptive cross-sectional study of 2261 in-school adolescent girls aged 10 -19 was conducted. A multistage stratified random sampling procedure was used to select participants from three geopolitical zones in Nigeria. Two states selected from each zone; North Central (Kogi and Niger States), South East (Abia and Imo States) and South West (Osun and Ondo States). Body Mass Index-for-age, Waist-Hip-Ratio (WHR), and Waist-Height-Ratio were calculated by anthropometry of weight, height, hip, waist and Mid-Upper Arm Circumferences. Data were analysed on SPSS Version 24. Frequency, percentages, mean and standard deviations were used for descriptive while logistic regression and chi-square analyses were used for inferential statistics. Significance was taken at p<0.05. Results: Mean age was 14.86 years (± 1.78 years) and actual body weight was 47.81 kg (± 9.02 kg), which is lower than the ideal weight of 54.52 kg (± 9.05 kg). The negative variance of -6.71 kg shows that the girls weighed 6.71 (±9.73) kg less than their ideal weight. Overweight/Obesity/Risk of Abdominal Obesity was highest in South East region (p = .005) while underweight/undernourishment was highest in South West (p = .005). However, no significant difference was recorded between the urban and peri-urban populations (p = .005). Older girls; 14 -16yrs (OR = 2.311, 95%CI = 1.263 – 4.229) and 17 -19yrs (OR = 2.182, 95%CI = 1.253 – 3.799) were twice more likely to be Overweight/Obesity compared to 10 -13yrs. Those who were within the 14 -16yrs age range were thrice more likely to have higher WHR (OR = 3.043 95%CI = 2.334 -3.978) than those younger. Conclusion: There was a significant difference in the nutritional status of adolescent girls across regions and age ranges hence a need for regional nutrition-sensitive intervention programmes among adolescent girls. Keywords: High School Girls; Health Status; Body Stature; Body Measurement; Nigeria Region
Article
Full-text available
Background and aims Exclusive enteral nutrition (EN) is often observed during the first week of ICU admission because of the extra costs and safety considerations for early parenteral nutrition. This study aimed to assess the association between nutrition intake and 28-day mortality in critically ill patients receiving exclusive EN. Methods This is a post hoc analysis of a cluster-randomized clinical trial that assesses the effect of implementing a feeding protocol on mortality in critically ill patients. Patients who stayed in the ICUs for at least 7 days and received exclusive EN were included in this analysis. Multivariable Cox hazard regression models and restricted cubic spline models were used to assess the relationship between the different doses of EN delivery and 28-day mortality. Subgroups with varying lactate levels at enrollment were additionally analyzed to address the potential confounding effect brought in by the presence of shock-related hypoperfusion. Results Overall, 1322 patients were included in the analysis. The median (interquartile range) daily energy and protein delivery during the first week of enrollment were 14.6 (10.3–19.6) kcal/kg and 0.6 (0.4–0.8) g/kg, respectively. An increase of 5 kcal/kg energy delivery was associated with a significant reduction (approximately 14%) in 28-day mortality (adjusted hazard ratio [HR] = 0.865, 95% confidence interval [CI]: 0.768–0.974, P = 0.016). For protein intake, a 0.2 g/kg increase was associated with a similar mortality reduction with an adjusted HR of 0.868 (95% CI 0.770–0.979). However, the benefits associated with enhanced nutrition delivery could be observed in patients with lactate concentration ≤ 2 mmol/L (adjusted HR = 0.804 (95% CI 0.674–0.960) for energy delivery and adjusted HR = 0.804 (95% CI 0.672–0.962) for protein delivery, respectively), but not in those > 2 mmol/L. Conclusions During the first week of critical illness, enhanced nutrition delivery is associated with reduced mortality in critically ill patients receiving exclusive EN, only for those with lactate concentration ≤ 2 mmol/L. Trial registration : ISRCTN12233792, registered on November 24, 2017.
Chapter
Accurate and robust estimation of the patient’s height and weight is essential for many clinical imaging workflows. Patient’s safety, as well as a number of scan optimizations, rely on this information. In this paper we present a deep-learning based method for estimating the patient’s height and weight in unrestricted clinical environments using depth images from a 3-dimensional camera. We train and validate our method on a very large dataset of more than 1850 volunteers and/or patients captured in more than 7500 clinical workflows. Our method achieves a PH5 of 98.4% and a PH15 of 99.9% for height estimation, and a PW10 of 95.6% and a PW20 of 99.8% for weight estimation, making the proposed method state-of-the-art in clinical setting.
Article
Full-text available
Background: Ideal body weight (IBW) equations and body mass index (BMI) ranges have both been used to delineate healthy or normal weight ranges, although these 2 different approaches are at odds with each other. In particular, past IBW equations are misaligned with BMI values, and unlike BMI, the equations have failed to recognize that there is a range of ideal or target body weights. Objective: For the first time, to our knowledge, we merged the concepts of a linear IBW equation and of defining target body weights in terms of BMI. Design: With the use of calculus and approximations, we derived an easy-to-use linear equation that clinicians can use to calculate both IBW and body weight at any target BMI value. We measured the empirical accuracy of the equation with the use of NHANES data and performed a comparative analysis with past IBW equations. Results: Our linear equation allowed us to calculate body weights for any BMI and height with a mean empirical accuracy of 0.5–0.7% on the basis of NHANES data. Moreover, we showed that our body weight equation directly aligns with BMI values for both men and women, which avoids the overestimation and underestimation problems at the upper and lower ends of the height spectrum that have plagued past IBW equations. Conclusions: Our linear equation increases the sophistication of IBW equations by replacing them with a single universal equation that calculates both IBW and body weight at any target BMI and height. Therefore, our equation is compatible with BMI and can be applied with the use of mental math or a calculator without the need for an app, which makes it a useful tool for both health practitioners and the general public.
Article
Full-text available
The epidemic of overweight and obesity presents a major challenge to chronic disease prevention and health across the life course around the world. Fueled by economic growth, industrialization, mechanized transport, urbanization, an increasingly sedentary lifestyle, and a nutritional transition to processed foods and high-calorie diets over the last 30 years, many countries have witnessed the prevalence of obesity in its citizens double and even quadruple. A rising prevalence of childhood obesity, in particular, forebodes a staggering burden of disease in individuals and healthcare systems in the decades to come. A complex, multifactorial disease, with genetic, behavioral, socioeconomic, and environmental origins, obesity raises the risk of debilitating morbidity and mortality. Relying primarily on epidemiologic evidence published within the last decade, this non-exhaustive review discusses the extent of the obesity epidemic, its risk factors-known and novel-, sequelae, and economic impact across the globe.
Article
Full-text available
To provide a historical perspective on the origin and similarity of the "ideal" body weight (IBW) equations, and clarify the terms ideal and lean body weight (LBW). Primary and review literature were identified using MEDLINE (1966-November 1999) and International Pharmaceutical Abstracts (1970-November 1999) pertaining to ideal and lean weight, height-weight tables, and obesity. In addition, textbooks and relevant reference lists were reviewed. All articles identified through the data sources were evaluated. Information deemed to be relevant to the objectives of the review were included. Height-weight tables were generated to provide a means of comparing a population with respect to their relative weight. The weight data were found to correlate with mortality and resulted in the use of the terms desirable or ideal to describe these weights. Over the years, IBW was interpreted to represent a "fat-free" weight and thus was used as a surrogate for LBW. In addition, the pharmacokinetics of certain drugs were found to correlate with IBW and resulted in the use of IBW equations published by Devine. These equations were consistent with an old rule that was developed from height-weight tables to estimate IBW. Efforts to improve the IBW equations through regression analyses of height-weight data resulted in equations similar to those published by Devine. The similarity between the IBW equations was a result of the general agreement among the various height-weight tables from which they were derived. Therefore, any one of these equations may be used to estimate IBW.
Article
Full-text available
Estimates of the relative mortality risks associated with normal weight, overweight, and obesity may help to inform decision making in the clinical setting. To perform a systematic review of reported hazard ratios (HRs) of all-cause mortality for overweight and obesity relative to normal weight in the general population. PubMed and EMBASE electronic databases were searched through September 30, 2012, without language restrictions. Articles that reported HRs for all-cause mortality using standard body mass index (BMI) categories from prospective studies of general populations of adults were selected by consensus among multiple reviewers. Studies were excluded that used nonstandard categories or that were limited to adolescents or to those with specific medical conditions or to those undergoing specific procedures. PubMed searches yielded 7034 articles, of which 141 (2.0%) were eligible. An EMBASE search yielded 2 additional articles. After eliminating overlap, 97 studies were retained for analysis, providing a combined sample size of more than 2.88 million individuals and more than 270,000 deaths. Data were extracted by 1 reviewer and then reviewed by 3 independent reviewers. We selected the most complex model available for the full sample and used a variety of sensitivity analyses to address issues of possible overadjustment (adjusted for factors in causal pathway) or underadjustment (not adjusted for at least age, sex, and smoking). Random-effects summary all-cause mortality HRs for overweight (BMI of 25-<30), obesity (BMI of ≥30), grade 1 obesity (BMI of 30-<35), and grades 2 and 3 obesity (BMI of ≥35) were calculated relative to normal weight (BMI of 18.5-<25). The summary HRs were 0.94 (95% CI, 0.91-0.96) for overweight, 1.18 (95% CI, 1.12-1.25) for obesity (all grades combined), 0.95 (95% CI, 0.88-1.01) for grade 1 obesity, and 1.29 (95% CI, 1.18-1.41) for grades 2 and 3 obesity. These findings persisted when limited to studies with measured weight and height that were considered to be adequately adjusted. The HRs tended to be higher when weight and height were self-reported rather than measured. Relative to normal weight, both obesity (all grades) and grades 2 and 3 obesity were associated with significantly higher all-cause mortality. Grade 1 obesity overall was not associated with higher mortality, and overweight was associated with significantly lower all-cause mortality. The use of predefined standard BMI groupings can facilitate between-study comparisons.
Article
Full-text available
A high body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) is associated with increased mortality from cardiovascular disease and certain cancers, but the precise relationship between BMI and all-cause mortality remains uncertain. We used Cox regression to estimate hazard ratios and 95% confidence intervals for an association between BMI and all-cause mortality, adjusting for age, study, physical activity, alcohol consumption, education, and marital status in pooled data from 19 prospective studies encompassing 1.46 million white adults, 19 to 84 years of age (median, 58). The median baseline BMI was 26.2. During a median follow-up period of 10 years (range, 5 to 28), 160,087 deaths were identified. Among healthy participants who never smoked, there was a J-shaped relationship between BMI and all-cause mortality. With a BMI of 22.5 to 24.9 as the reference category, hazard ratios among women were 1.47 (95 percent confidence interval [CI], 1.33 to 1.62) for a BMI of 15.0 to 18.4; 1.14 (95% CI, 1.07 to 1.22) for a BMI of 18.5 to 19.9; 1.00 (95% CI, 0.96 to 1.04) for a BMI of 20.0 to 22.4; 1.13 (95% CI, 1.09 to 1.17) for a BMI of 25.0 to 29.9; 1.44 (95% CI, 1.38 to 1.50) for a BMI of 30.0 to 34.9; 1.88 (95% CI, 1.77 to 2.00) for a BMI of 35.0 to 39.9; and 2.51 (95% CI, 2.30 to 2.73) for a BMI of 40.0 to 49.9. In general, the hazard ratios for the men were similar. Hazard ratios for a BMI below 20.0 were attenuated with longer-term follow-up. In white adults, overweight and obesity (and possibly underweight) are associated with increased all-cause mortality. All-cause mortality is generally lowest with a BMI of 20.0 to 24.9.
Article
Article
The association between obesity and prognosis in patients with coronary artery disease (CAD) remains uncertain. We undertook a meta-analysis for the effects of body mass index (BMI) on mortality and cardiovascular events in these patients. We identified studies that provided risk estimates for mortality or cardiovascular events on the basis of BMI in patients with CAD. Summary estimates of relative risks were obtained for five BMI groups: underweight, normal-weight, overweight, obese and grade II/III obese. Mortality was analysed separately as short-term (<6 months) and long-term (≥6 months). Data from 89 studies with 1 300 794 patients were included. Mean follow-up of long-term estimates was 3.2 years. Using normal-weight as the reference, underweight was associated with higher risk of short-term mortality (2.24 (1.85 to 2.72)) and long-term mortality (1.70 (1.56 to 1.86)), overweight and obesity were both associated with lower risk of short-term mortality (0.69 (0.64 to 0.75); 0.68 (0.61 to 0.75)) and long-term mortality (0.78 (0.74 to 0.82); 0.79 (0.73 to 0.85)), but the long-term benefit of obesity disappeared after 5 years of follow-up (0.99 (0.91 to 1.08)). Grade II/III obesity was associated with lower risk of mortality in the short term (0.76 (0.62 to 0.91)) but higher risk after 5 years of follow-up (1.25 (1.14 to 1.38)). The similar J-shaped pattern was also seen for cardiovascular mortality and across different treatment strategies. Meta-regression found an attenuation of the inverse association between BMI and risk of mortality over longer follow-up. Our data support a J-shaped relationship between mortality and BMI in patients with CAD. The limitation of current literature warrants better design of future studies. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Article
Obesity is a condition of increased adipose tissue mass. Many techniques are available for measurement of body fat, but none is available widely for clinical purposes. The new technique of bioelectrical impedance may change this in the future. For now, relative weight and BMI are used as indices of obesity, which may be defined as a BMI greater than 30 kg per m2. This corresponds to a relative weight approximately 120 per cent above desirable. According to this definition, obesity exists in 10 to 12 per cent of adult men and women in the United States and Canada.